Kim G Johnson

Associate Professor of Psychiatry and Behavioral Sciences · 2025 - Present Psychiatry & Behavioral Sciences, Adult Psychiatry & Psychology, Psychiatry & Behavioral Sciences

Division Chief, Memory Disorders in the Department of Neurology · 2019 - Present Neurology, Clinical Science Departments

Associate Professor in Neurology · 2025 - Present Neurology, Behavioral Neurology, Neurology

In the News

Published February 3, 2025

Assessing and Educating Patients About Mild Cognitive Impairment

Published January 22, 2025

Alzheimer's Clinic Provides Time and Hope

Published January 9, 2025

Dementia - Impact Not Just on Patients but on Families

View All News

Recent Publications

Evaluating the Duke Iterative Cognitive Examination Against the Montreal Cognitive Assessment: Validity and Clinical Utility.

Journal Article Neurol Clin Pract · June 2026 BACKGROUND AND OBJECTIVES: Rapid and valid cognitive screening tools are a mainstay of clinical practice in the assessment of mild cognitive impairment and dementia. Although there are several available tools, there is concern for reduced sensitivity over ... Full text Link to item Cite

Cerebrospinal fluid amyloid-β 42/40 ratio is associated with ganglion cell-inner plexiform layer thinning in individuals with and without amyloid pathology.

Journal Article J Alzheimers Dis · April 2026 BackgroundRetinal imaging offers a noninvasive window into neurodegenerative changes, yet its relationship with established cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) remains poorly understood. This study addresses a critical gap by e ... Full text Link to item Cite

Comparison of Longitudinal Retinal and Choroidal Imaging Findings in Patients With Mild Cognitive Impairment and Cognitively Normal Control Participants

Journal Article Journal of Vitreoretinal Diseases · January 1, 2026 Purpose: To compare longitudinal retinal and choroidal imaging findings in patients with mild cognitive impairment and cognitively normal control participants. Methods: Eyes of patients with mild cognitive impairment and cognitively normal controls were im ... Full text Cite

View All Publications

Recent Grants

Long-term Follow-up to Evaluate the Safety of LX1001 in Participants with APOE4 Homozygote Alzheimer's Disease.

Clinical TrialPrincipal Investigator · Awarded by LEXEO Therapeutics, Inc · 2024 - 2029

A 6-month & 18-month prospective, randomized, placebo-controlled, double-blind dual clinical trial investigating efficacy and safety of buntanetap in treating participants of early Alzheimer's disea

Clinical TrialPrincipal Investigator · Awarded by Annovis Bio, Inc. · 2025 - 2028

Biopsy-based single cell assays for olfactory sensory changes in an Alzheimer's Disease cohort

ResearchCo Investigator · Awarded by National Institute on Aging · 2024 - 2028

View All Grants

Education

University of Pittsburgh, School of Medicine · 1999 M.D.